Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus.
<h4>Unlabelled</h4>Metformin, a biguanide derivate, has pleiotropic effects beyond glucose reduction, including improvement of lipid profiles and lowering microvascular and macrovascular complications associated with type 2 diabetes mellitus (T2DM). These effects have been ascribed to ad...
Enregistré dans:
Auteurs principaux: | Antonella Napolitano, Sam Miller, Andrew W Nicholls, David Baker, Stephanie Van Horn, Elizabeth Thomas, Deepak Rajpal, Aaron Spivak, James R Brown, Derek J Nunez |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/0210c4a3a2ff4b068af2ccf58d9a2e0f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus
par: Zhang Q, et autres
Publié: (2020) -
Metformin action over gut microbiota is related to weight and glycemic control in gestational diabetes mellitus: A randomized trial
par: María Molina-Vega, et autres
Publié: (2022) -
Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
par: Holl, et autres
Publié: (2014) -
Hormonal, metabolic and genetic predictors of metformin efficacy in patients with diabetes mellitus and cancer
par: Lev Mikhaylovich Bershteyn, et autres
Publié: (2014) -
Metformin regulates glycemic homeostasis in patients with type 2 diabetes mellitus as an NO donor
par: Ivan Sergeevich Kuznetsov, et autres
Publié: (2013)